- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01772693
ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease
A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease.
This is a feasibility study to evaluate the safety and initial effectiveness of unilateral ExAblate thermal ablation of the Vim thalamic nucleus of subjects suffering from medication-refractory, idiopathic, tremor-dominant PD, using the ExAblate Transcranial system compared to a Sham Vim thalamotomy procedure.
Data will be collected to establish the basic safety of this type of treatment as the basis for later studies that will evaluate its full clinical efficacy. The Sham treatment data will be used to evaluate placebo effect from treatment.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Virginia
-
Charlottesville, Virginia, Estados Unidos, 22908
- University of Virginia
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98122
- Swedish Medical Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Men and women, age 30 years and older
- Subjects who are able and willing to give informed consent and able to attend all study visits
- Subjects with a diagnosis of idiopathic PD as confirmed from clinical history and examination by a movement disorder neurologist at the site
- Subject demonstrates a severe resting tremor or postural/action as measured by UPDRS
- Subject exhibits a significant disability from their PD tremor despite medical treatment
- Subjects should be on a stable dose of all PD medications for 30 days prior to study entry
- Subject is able to communicate sensations during the ExAblate Transcranial procedure
Exclusion Criteria:
- Subjects with unstable cardiac status
- Subjects exhibiting any behavior(s) consistent with ethanol or substance abuse
- Severe hypertension
- Subjects with standard contraindications for MR imaging such as non-MRI compatible implanted metallic devices including cardiac pacemakers, size limitations, etc.
- Known intolerance or allergies to the MRI contrast agent including advanced kidney disease or severely impaired renal function
- Significant claustrophobia that cannot be managed with mild medication
- Current medical condition resulting in abnormal bleeding and/or coagulopathy
- Receiving anticoagulant (e.g. warfarin) or antiplatelet (e.g. aspirin) therapy within one week of focused ultrasound procedure or drugs known to increase risk or hemorrhage
- History of intracranial hemorrhage
- History of multiple strokes, or a stroke within past 6 months
- Subjects who are not able or willing to tolerate the required prolonged stationary supine position during treatment
- Are participating or have participated in another clinical trial in the last 30 days
- Subjects unable to communicate with the investigator and staff
- Subjects with a history of seizures within the past year
- Subjects with brain tumors
- Subjects with intracranial aneurysms requiring treatment or arterial venous malformations (AVMs) requiring treatment
- Subjects who have had deep brain stimulation or a prior stereotactic ablation of the basal ganglia
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: ExAblate Transcranial MRgFUS
ExAblate Transcranial MR guided Focused Ultrasound
|
ExAblate Transcranial MR Guided Focused Ultrasound
Otros nombres:
|
Comparador falso: Sham ExAblate Transcranial MRgFUS
Sham treatment with ExAblate MR guided Focused Ultrasound
|
Sham ExAblate Transcranial MR Guided Focused Ultrasound
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Number of Adverse Events
Periodo de tiempo: Month 3
|
Evaluate of adverse events (AEs) associated with the ExAblate Transcranial thalamotomy of medication-refractory, tremor-dominant PD during the ExAblate treatment. Primary safety analyses are reported in the adverse events module. |
Month 3
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Tremor Motor Score Percent Change From Baseline.
Periodo de tiempo: Baseline, Month 3
|
The percent change from baseline to Month 3 follow-up in upper extremity Tremor-Motor scores for the treated side is a sub-scale of Clinical Rating Scale for Tremor (CRST) Part A and Part B sum that was used to measure treated-side upper extremity tremor changes over time.
Tremor-motor scores range from 0-32 points.
Individual subject's scores at Baseline and 3 Months were used to calculate percent change from baseline and averaged across subjects.
High percent change from baseline is better (shows improvement).
|
Baseline, Month 3
|
Tremor Motor Scores - Clinical Rating Scale for Tremor - Treated Side Upper Extremity Parts A & B.
Periodo de tiempo: Baseline, Month 3, Month 12
|
Upper extremity Tremor-Motor score for the treated side is a sub-scale of Clinical Rating Scale for Tremor (CRST) Part A and Part B sum that measures treated-side upper extremity tremor changes over time.
Tremor-motor scores range from 0-32 points for each side with lower scores being a better outcome.
Subject's Tremor-Motor scores for the test and sham control groups were averaged at each study visit.
|
Baseline, Month 3, Month 12
|
Functional Disabilities - Clinical Rating Scale for Tremor Part C - Functional Disabilities
Periodo de tiempo: Baseline, Month 3, Month 12
|
The Clinical Rating Scale for Tremor (CRST) Part C is a measure of functional disability due to tremor.
The Clinical Rating Scale for Tremor Part C consists of 8 items each scored from 0 to 4. Thus, the total score summed ranges from 0 to 32 and provides an overall assessment of activities of daily living.
Low scores on the Clinical Rating Scale for Tremor (CRST) Part C are better.
Low scores show improvement in functional disabilities compared to higher scores.
|
Baseline, Month 3, Month 12
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Jeff Elias, M.D., University of Virginia
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- PD001
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre ExAblate Transcranial MRgFUS
-
National and Kapodistrian University of AthensTerminadoEnfermedad de FabryGrecia
-
InSightecTerminadoCáncer de mamaAlemania
-
Matthew BucknorFocused Ultrasound FoundationReclutamientoOsteoma osteoideEstados Unidos
-
University of Roma La SapienzaDesconocidoNeoplasia maligna secundaria de huesoItalia
-
Istituto Ortopedico RizzoliTerminadoOsteoartritis | Artrosis de mano | Artrosis de caderaItalia
-
Matthew BucknorFocused Ultrasound Foundation; InSightec-TxSonicsReclutamientoSarcoma pleomórfico indiferenciadoEstados Unidos
-
Istituto Ortopedico RizzoliTerminadoOsteoartritis | Artrosis, Rodilla | Osteo Artritis RodillaItalia
-
Chinese PLA General HospitalReclutamientoTrastornos del movimientoPorcelana
-
InSightecTerminadoTemblor esencialPorcelana, Japón, Taiwán
-
InSightecActivo, no reclutandoEnfermedad de ParkinsonEstados Unidos, España, Taiwán